Abbott Laboratories (ABT) Tops Q1 EPS by 5c; Reaffirms FY14 Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $107.59 --0%
Revenue Growth %: +2.2%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Revenue Growth %: +2.2%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q1 ongoing EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $5.24 billion versus the consensus estimate of $5.29 billion.
Abbott reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
- Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance
- Hasbro (HAS) Tops Q1 EPS by 33c, offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
